Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity-Reference-Cited by-同舟云学术

Changes in systemic vascular endothelial growth factor levels after intravitreal injection of aflibercept in infants with retinopathy of prematurity

Published:2017-12-30 Issue:3 Volume:256 Page:479-487
ISSN:0721-832X
Container-title:Graefe's Archive for Clinical and Experimental Ophthalmology
language:en
Short-container-title:Graefes Arch Clin Exp Ophthalmol

Author:

Huang Chung-Ying,Lien Reyin,Wang Nan-Kai,Chao An-Ning,Chen Kuan-Jen,Chen Tun-Lu,Hwang Yih-Shiou,Lai Chi-Chun,Wu Wei-Chi

Funder

Chang Gung Memorial Hospital Grants

National Science Council Research

Publisher

Springer Science and Business Media LLC

Subject

Cellular and Molecular Neuroscience,Sensory Systems,Ophthalmology

Link

http://link.springer.com/article/10.1007/s00417-017-3878-4/fulltext.html

Reference43 articles.

1. Stone J, Chan-Ling T, Pe'er J et al (1996) Roles of vascular endothelial growth factor and astrocyte degeneration in the genesis of retinopathy of prematurity. Invest Ophthalmol Vis Sci 37:290–299

2. Mutlu FM, Sarici SU (2013) Treatment of retinopathy of prematurity: a review of conventional and promising new therapeutic options. Int J Ophthalmol 6:228–236

3. Wu WC, Kuo HK, Yeh PT et al (2013) An updated study of the use of bevacizumab in the treatment of patients with prethreshold retinopathy of prematurity in Taiwan. Am J Ophthalmol 155:150–158

4. Mintz-Hittner HA, Kennedy KA, Chuang AZ (2011) BEAT-ROP cooperative Group.Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med 364:603–615

5. Heier JS, Brown DM, Chong V et al (2012) Intravitreal aflibercept (VEGF trap-eye) in wet age-related macular degeneration. Ophthalmology 119:2537–2548

Cited by 66 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating VEGF-A Levels in Relation to Retinopathy of Prematurity and Treatment Effects: A Systematic Review and Meta-Analysis;Ophthalmology Science;2024-11

2. Case report: heart failure related to intravitreal injection of anti-VEGF;BMC Cardiovascular Disorders;2024-08-12

3. Aflibercept to treat retinopathy of prematurity: need for more research;Journal of Perinatology;2024-05-10

4. A comparative study of stereopsis in term and preterm children with and without retinopathy of prematurity;Graefe's Archive for Clinical and Experimental Ophthalmology;2024-03-20

5. Comparison of different agents and doses of anti-vascular endothelial growth factors (aflibercept, bevacizumab, conbercept, ranibizumab) versus laser for retinopathy of prematurity: A network meta-analysis;Survey of Ophthalmology;2024-03